Nr (Nicotinamide Riboside) for Neuroprotection

Research suggests that NAD+ precursor metabolism plays a meaningful role in axon degeneration and neuroprotection, with one preclinical study in fruit flies finding that reducing levels of NMN — a molecule closely related to NR in the NAD+ biosynthesis pathway — dramatically slowed the breakdown of damaged axons and preserved their functional connections to neural circuits for extended periods. The same study indicated that elevated NMN accelerated degeneration through activation of a destruction-signaling protein called dSarm, and that lowering NMN also slowed neurodegeneration driven by genetic factors unrelated to physical injury, suggesting a broader role for this metabolic pathway. It is important to note that the available evidence on this specific question consists of a single animal study conducted in Drosophila, and findings in fruit flies do not necessarily translate to humans. No human clinical trials examining NR specifically for neuroprotection were included in the reviewed literature, so conclusions about relevance to human neurological health cannot be drawn from this evidence base alone.